Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg)
José Alfredo Sierra-Ramírez, Roger Lara-Ricalde, Miguel Lujan, Norma Velázquez-Ramírez, Marycarmen Godínez-Victoria, Ivonne Araceli Hernádez-Munguía, Agustin Padilla, Josué Garza-Flores, José Alfredo Sierra-Ramírez, Roger Lara-Ricalde, Miguel Lujan, Norma Velázquez-Ramírez, Marycarmen Godínez-Victoria, Ivonne Araceli Hernádez-Munguía, Agustin Padilla, Josué Garza-Flores
Index: Contraception 84(6) , 565-70, (2011)
Full Text: HTML
Abstract
Background The efficacy of contraceptives is affected by its route and ease of administration. Herein, both pharmacokinetics and pharmacodynamics of the once-a-month combined injectable contraceptive medroxyprogesterone acetate (MPA) plus estradiol cypionate (E 2-Cyp) were compared after intramuscular (IM) or subcutaneous (SC) injection in women of reproductive age.
Related Compounds
Related Articles:
2007-10-01
[Endocrinology 148(10) , 4761-73, (2007)]
2008-03-01
[J. Neuroimmunol. , (2008)]
2012-08-01
[Theriogenology 78(3) , 510-6, (2012)]
2009-11-01
[Hum. Reprod. 24(11) , 2688-92, (2009)]
2011-12-01
[Trop. Anim. Health Prod. 43(8) , 1595-600, (2011)]